Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PODN | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | PRMT1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | STX6 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | BMP15 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | TNFRSF13C | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | CCDC71L | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | PABPC1L | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | SRD5A3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | RASA4 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |